ResMed Inc. reported its Q4 2025 earnings, revealing a robust financial performance with revenue reaching $1.35 billion, surpassing the forecast of $1.33 billion. Despite this positive financial ...

ResMed (NYSE:RMD) underwent analysis by 9 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. Summarizing their recent assessments, the table below illustrates ...

Investors in ResMed Inc. RMD need to pay close attention to the stock based on moves in the options market lately. That is because the Jan. 16, 2026 $155.00 Call had some of the highest implied ...

Resmed Inc. (ASX: RMD) The Resmed share price is down 4% to $37.86. This follows a poor night of trade for the sleep disorder treatment company's NYSE listed shares on Friday, which has reversed its ...

Provides digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, chronic obstructive pulmonary disease or COPD, and other chronic diseases.

This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed.

Find the latest ResMed Inc. (RMD) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.

Chinese technology heavyweight Huawei Technologies Co unveiled on Tuesday its inaugural luxury sedan, Stelato S9, in Beijing, targeting the premium electric sedan market in China. As the first jointly ...

The MFDC inverter resistance welding machine is a microprocessor-controlled system equipped with POWER GUN technology, enabling high spot-welding currents with low power draw, longer and lighter ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial, ...